Literature DB >> 9109522

Increased phosphorylation of myelin basic protein during hippocampal long-term potentiation.

C M Atkins1, S J Chen, E Klann, J D Sweatt.   

Abstract

Hippocampal long-term potentiation (LTP) is a long-lasting and rapidly induced increase in synaptic strength. Previous experiments have determined that persistent activation of protein kinase C (PKC) contributes to the early maintenance phase of LTP (E-LTP). Using the back-phosphorylation method, we observed an increase in the phosphorylation of a 21-kDa PKC substrate, termed p21, 45 min after LTP was induced in the CA1 region of the hippocampus. p21 was found to have the same apparent molecular weight as the 18.5-kDa isoform of myelin basic protein (MBP) and was recognized by an antibody to MBP in western blotting and immunoprecipitation. Furthermore, p21 from control and potentiated hippocampal slices and purified MBP have identical phosphopeptide maps when back-phosphorylated and then digested with either endoproteinase Lys-C or endoproteinase Asp-N, suggesting that p21 and MBP are identical proteins. As there was no observed change in the amount of MBP in LTP, the increase in MBP phosphorylation during LTP cannot be explained by a change in the amount of protein. From these experiments, we conclude that the phosphorylation of the 18.5-kDa isoform of MBP is increased during E-LTP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109522     DOI: 10.1046/j.1471-4159.1997.68051960.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys.

Authors:  Glenn T Konopaske; Karl-Anton Dorph-Petersen; Robert A Sweet; Joseph N Pierri; Wei Zhang; Allan R Sampson; David A Lewis
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

2.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

3.  Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder.

Authors:  Jessie S Chambers; Nora I Perrone-Bizzozero
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

4.  Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus.

Authors:  C M Atkins; J D Sweatt
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

5.  A role for ERK MAP kinase in physiologic temporal integration in hippocampal area CA1.

Authors:  Joel C Selcher; Edwin J Weeber; Jill Christian; Tanya Nekrasova; Gary E Landreth; J David Sweatt
Journal:  Learn Mem       Date:  2003 Jan-Feb       Impact factor: 2.460

Review 6.  Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms.

Authors:  George Harauz; Joan M Boggs
Journal:  J Neurochem       Date:  2013-03-06       Impact factor: 5.372

Review 7.  Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

Authors:  Madeline Halpern; Kristen J Brennand; James Gregory
Journal:  Neurobiol Dis       Date:  2019-08-02       Impact factor: 5.996

Review 8.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

Review 9.  The Hidden Notes of Redox Balance in Neurodegenerative Diseases.

Authors:  Silvia Piccirillo; Simona Magi; Alessandra Preziuso; Tiziano Serfilippi; Giorgia Cerqueni; Monia Orciani; Salvatore Amoroso; Vincenzo Lariccia
Journal:  Antioxidants (Basel)       Date:  2022-07-26

10.  Regulation of myelin genes implicated in psychiatric disorders by functional activity in axons.

Authors:  Philip R Lee; R Douglas Fields
Journal:  Front Neuroanat       Date:  2009-06-01       Impact factor: 3.856

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.